Mark Ta Donoghue

17PUBLICATIONS
339CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer geneticsNatural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Oct 10, 2026
CDKPredict: a clinicogenomic model for risk-adapted therapeutic intervention in breast cancer.

|Aug 31, 2026
Tumor CD19 Expression Determines Distinct Clinical Outcomes After CD19 CAR T-Cell Therapy in Large B-Cell Lymphoma.

|Aug 14, 2026
The pan-tumor landscape, allelic status, and genomic complexity of SMARCA4 alterations.

|Jun 24, 2026
The Genomic Landscape of MYC-, MYCL-, and MYCN-Amplified Solid Tumors.

|Mar 26, 2026
Pembrolizumab and olaparib in homologous-recombination-deficient metastatic pancreatic cancer: the phase 2 POLAR trial.

Wungki Park, Catherine A O'Connor, Joanne F Chou

|Mar 04, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancer.

Anton Safonov, Minna Lee, David N Brown

Pageof 3

Frequent Collaborators

10 joint publications

Michael F Berger

6 joint publications

Marc Ladanyi

6 joint publications

David Solit

5 joint publications

Allison L Richards